Strong US Sales Help; Design-a-Bear in Web Site Shortlist

Daily Post (Liverpool, England), September 3, 2003 | Go to article overview
Save to active project

Strong US Sales Help; Design-a-Bear in Web Site Shortlist


STRONG sales in the US of a diabetes diagnostic product have helped Deeside-based medical group Provalis report gross profits of of pounds 7.7m this year.

The group's preliminary results for the year ended June 30 showed the profit to be an increase of pounds 2.4m over last year,giving a margin on sales of 55pc.

After accounting for an exceptional gain of pounds 3.4m from the variation of the distribution agreement with Dr Falk Pharma, Provalis reports its first profit before tax of pounds 1.3m and a profit per share of 0.4pence.

The Group reduced its operating loss for its continuing businesses from pounds 4.2m in 2002 to pounds 1.7m in 2003.

Company bosses said the turnover increased by 49pc to pounds 14m in 2003 and was driven by sales of Glycosal in the US and Diclomax in the UK market.

The company's cash position remained healthy at pounds 6.6m,and will further benefit from additional payments of up to pounds 3.5m from Dr Falk Pharma which are due by January 2005, and the stopping in November 2004 of the monthly payments of more than pounds 380,000 to Pfizer for Diclomax.

Sales of the Glycosal instrument and test cartridges have been pleasing,according to the company.

Last year the group supplied over one million Glycosal cartridges for sale and shipped twice as many instruments as in the previous two years combined. Between 200-300 instruments continue to be placed with doctors in the US each month. However its sales in the UK have been disappointing and the group is now trying to address this.

Commenting on the full-year results, chairman Frank Harding said: ``2003 was a year of real progress for Provalis. Both businesses achieved substantial sales growth, with Glycosal making an important breakthrough in the valuable US diabetes market for Provalis' medical diagnostics business and Diclomax transforming the sales and profitability of our pharmaceutical business.''

Chief executive Dr Phil Gould said: ``Provalis had a strong year in 2003. The challenge for the group is to continue to grow sales and to develop new products in both of our businesses.

The rest of this article is only available to active members of Questia

Sign up now for a free, 1-day trial and receive full access to:

  • Questia's entire collection
  • Automatic bibliography creation
  • More helpful research tools like notes, citations, and highlights
  • Ad-free environment

Already a member? Log in now.

Notes for this article

Add a new note
If you are trying to select text to create highlights or citations, remember that you must now click or tap on the first word, and then click or tap on the last word.
Loading One moment ...
Project items
Cite this article

Cited article

Citations are available only to our active members.
Sign up now to cite pages or passages in MLA, APA and Chicago citation styles.

Cited article

Strong US Sales Help; Design-a-Bear in Web Site Shortlist


Text size Smaller Larger
Search within

Search within this article

Look up

Look up a word

  • Dictionary
  • Thesaurus
Please submit a word or phrase above.
Print this page

Print this page

Why can't I print more than one page at a time?

While we understand printed pages are helpful to our users, this limitation is necessary to help protect our publishers' copyrighted material and prevent its unlawful distribution. We are sorry for any inconvenience.
Full screen

matching results for page

Cited passage

Citations are available only to our active members.
Sign up now to cite pages or passages in MLA, APA and Chicago citation styles.

Cited passage

Welcome to the new Questia Reader

The Questia Reader has been updated to provide you with an even better online reading experience.  It is now 100% Responsive, which means you can read our books and articles on any sized device you wish.  All of your favorite tools like notes, highlights, and citations are still here, but the way you select text has been updated to be easier to use, especially on touchscreen devices.  Here's how:

1. Click or tap the first word you want to select.
2. Click or tap the last word you want to select.

OK, got it!

Thanks for trying Questia!

Please continue trying out our research tools, but please note, full functionality is available only to our active members.

Your work will be lost once you leave this Web page.

For full access in an ad-free environment, sign up now for a FREE, 1-day trial.

Already a member? Log in now.

Are you sure you want to delete this highlight?